China vaccine diplomacy wavers as nations seek western shots

China vaccine diplomacy wavers as nations seek western shots

In the early days of the Covid-19 vaccine rollout, Chinese shots saved countless lives. They kick-started inoculation programs across Asia, Latin America and the Middle East, while richer countries hoarded scarce mRNA shots from Inc. and Moderna Inc. But many governments that once relied on vaccines from Sinovac Biotech Ltd. or Sinopharm Group Co Ltd. … Read more

US to start offering COVID-19 vaccine booster doses in September

US to start offering COVID-19 vaccine booster doses in September

The U.S. government said on Wednesday it plans to make COVID-19 vaccine booster shots widely available to all Americans starting on Sept. 20 as infections rise from the Delta variant of the coronavirus. The White House is prepared to offer a third booster shot starting on that date to all Americans who completed their initial … Read more

Canada has deal to get Moderna COVID-19 vaccine within 48 hours of approval

Canada has deal to get Moderna COVID-19 vaccine within 48 hours of approval

OTTAWA, – Canadian Prime Minister Justin Trudeau will announce on Tuesday that the government has reached an agreement with Moderna Inc to receive the first deliveries of its COVID-19 vaccine within 48 hours of regulatory approval, the CBC said. The Canadian Broadcasting Corp gave no further details. Moderna’s vaccine is currently under review by Canada’s … Read more

Moderna Covid-19 vaccine documents accessed in EMA cyberattack – ET HealthWorld

Moderna Covid-19 vaccine documents accessed in EMA cyberattack – ET HealthWorld

Moderna Inc said on Monday it was informed by the European Medicines Agency (EMA) certain documents related to pre-submission talks of its Covid-19 vaccine candidate were unlawfully accessed in a cyberattack on the medicines regulator. The EMA, which assesses medicines and vaccines for the European Union, said earlier this month that it had been targeted … Read more

Moderna says more than 40% of participants enrolled for COVID-19 vaccine trial

Moderna says more than 40% of participants enrolled for COVID-19 vaccine trial

Moderna began the study of its vaccine candidate, mRNA-1273, in July and expects to complete enrollment in September. (Reuters photo) Drug developer Moderna Inc on Friday said it has so far enrolled 13,194 participants in the ongoing late-stage 30,000-volunteer U.S. trial testing its COVID-19 vaccine candidate. In a tweet, the company also said that 18% … Read more